ProfileGDS4459 / ENSG00000152291
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 85% 85% 85% 78% 82% 83% 84% 85% 86% 87% 83% 81% 83% 80% 85% 79% 83% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.4485
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.4485
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.6985
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.7178
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.3982
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.3683
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.6184
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.7385
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.8486
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.9187
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.4383
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.3881
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.4683
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.8880
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.7385
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.8379
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.2983